Test of an mRNA vaccine for mpox in Africa
Part of Infections clinical trials.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older, with specific age limits depending on your group.
- If you have never had mpox or a smallpox/mpox vaccine, you can join one group.
- If you have had mpox or a smallpox/mpox vaccine at least 2 years ago, you can join another group.
- You cannot have been near someone with mpox in the last 28 days or have had mpox or its vaccine in the last 2 years.
- You cannot have a history of certain heart problems, bleeding disorders, or serious allergies to vaccine ingredients.
- Your body mass index (BMI) must be between 18.5 and 35.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
This study is testing a new way to diagnose mpox (formerly monkeypox) using a sample from your skin sores. If you have symptoms that look like mpox, this test might help confirm the diagnosis quickly.
This study looks at how well your immune system remembers the mpox virus after you've been infected. It may help researchers understand protection against future infections.
This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.